These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 14633174)
1. A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis. Iavarone M; Lampertico P; Ronchi G; Del Ninno E; Zanella A; Colombo M J Viral Hepat; 2003 Nov; 10(6):423-6. PubMed ID: 14633174 [TBL] [Abstract][Full Text] [Related]
2. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis? Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381 [TBL] [Abstract][Full Text] [Related]
3. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]. Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471 [TBL] [Abstract][Full Text] [Related]
4. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis. Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481 [No Abstract] [Full Text] [Related]
6. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR. Yan D; He Q; Chen Y; Wang L; Zhang X J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004 [TBL] [Abstract][Full Text] [Related]
7. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394 [TBL] [Abstract][Full Text] [Related]
9. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma. El-Mazny A; Sayed M; Sharaf S Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis. Worland T; Harrison B; Delmenico L; Dowling D J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172 [TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Lemoine A; Le Bricon T; Salvucci M; Azoulay D; Pham P; Raccuia J; Bismuth H; Debuire B Ann Surg; 1997 Jul; 226(1):43-50. PubMed ID: 9242336 [TBL] [Abstract][Full Text] [Related]
12. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein. Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study. Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma. Marubashi S; Nagano H; Wada H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M Ann Surg Oncol; 2011 Aug; 18(8):2200-9. PubMed ID: 21301972 [TBL] [Abstract][Full Text] [Related]
16. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection. Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823 [TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma. Kong SY; Park JW; Kim JO; Lee NO; Lee JA; Park KW; Hong EK; Kim CM J Cancer Res Clin Oncol; 2009 Aug; 135(8):1091-8. PubMed ID: 19184104 [TBL] [Abstract][Full Text] [Related]
18. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis. Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149 [TBL] [Abstract][Full Text] [Related]
19. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Ijichi M; Takayama T; Matsumura M; Shiratori Y; Omata M; Makuuchi M Hepatology; 2002 Apr; 35(4):853-60. PubMed ID: 11915031 [TBL] [Abstract][Full Text] [Related]
20. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Gopal P; Yopp AC; Waljee AK; Chiang J; Nehra M; Kandunoori P; Singal AG Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]